Filing Details

Accession Number:
0001181431-13-048231
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-09 16:13:51
Reporting Period:
2013-09-05
Filing Date:
2013-09-09
Accepted Time:
2013-09-09 16:13:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236934 J Paula Swain Experimental Station
Route 141 &Amp; Henry Clay Road
Wilmington DE 19880
Evp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-05 94,444 $7.09 112,505 No 4 M Direct
Common Stock Disposition 2013-09-05 94,444 $35.06 18,061 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-09-05 94,444 $0.00 94,444 $7.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-02-11 No 4 M Direct
Footnotes
  1. Beginning February 12, 2007, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
  2. Represents weighted average sale price. Actual sales prices ranged from $34.89-$35.25.
  3. Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.